Luis Llorente

5.8k total citations
154 papers, 4.4k citations indexed

About

Luis Llorente is a scholar working on Immunology, Rheumatology and Oncology. According to data from OpenAlex, Luis Llorente has authored 154 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Immunology, 54 papers in Rheumatology and 28 papers in Oncology. Recurrent topics in Luis Llorente's work include Systemic Lupus Erythematosus Research (42 papers), T-cell and B-cell Immunology (33 papers) and Immune Cell Function and Interaction (21 papers). Luis Llorente is often cited by papers focused on Systemic Lupus Erythematosus Research (42 papers), T-cell and B-cell Immunology (33 papers) and Immune Cell Function and Interaction (21 papers). Luis Llorente collaborates with scholars based in Mexico, United States and France. Luis Llorente's co-authors include D Alarcón-Segovia, Yvonne Richaud‐Patín, Jorge Alcocer‐Varela, Pierre Galanaud, Alejandro Ruı́z-Argüelles, John Wijdenes, Yemil Atisha‐Fregoso, Guadalupe Lima, Jorge Sánchez‐Guerrero and Hilda Fragoso-Loyo and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Luis Llorente

147 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Llorente Mexico 35 2.3k 1.8k 646 643 626 154 4.4k
Kenneth M. Kaufman United States 32 2.2k 0.9× 1.8k 1.0× 524 0.8× 590 0.9× 806 1.3× 87 4.0k
Jorge Alcocer‐Varela Mexico 38 3.4k 1.5× 2.7k 1.5× 626 1.0× 595 0.9× 610 1.0× 151 5.6k
Shunsei Hirohata Japan 39 1.9k 0.8× 2.7k 1.5× 832 1.3× 509 0.8× 674 1.1× 211 5.2k
Paola Migliorini Italy 42 2.4k 1.0× 2.0k 1.1× 1.1k 1.7× 497 0.8× 1.3k 2.1× 183 5.2k
Thierry Martin France 33 2.2k 0.9× 1.3k 0.7× 785 1.2× 488 0.8× 1.3k 2.0× 152 5.2k
Michael J. Townsend United States 30 3.0k 1.3× 1.2k 0.7× 457 0.7× 675 1.0× 771 1.2× 53 4.6k
Eric S. Sobel United States 38 2.8k 1.2× 1.8k 1.0× 670 1.0× 513 0.8× 801 1.3× 108 4.3k
Shingo Nakayamada Japan 42 2.8k 1.2× 2.5k 1.4× 585 0.9× 1.1k 1.7× 1.3k 2.1× 219 6.3k
Frédérique Ponchel United Kingdom 36 1.6k 0.7× 1.4k 0.8× 504 0.8× 728 1.1× 1.1k 1.7× 108 4.3k
Naoyuki Tsuchiya Japan 42 2.9k 1.2× 1.7k 0.9× 1.1k 1.7× 471 0.7× 1.3k 2.0× 168 5.3k

Countries citing papers authored by Luis Llorente

Since Specialization
Citations

This map shows the geographic impact of Luis Llorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Llorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Llorente more than expected).

Fields of papers citing papers by Luis Llorente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Llorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Llorente. The network helps show where Luis Llorente may publish in the future.

Co-authorship network of co-authors of Luis Llorente

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Llorente. A scholar is included among the top collaborators of Luis Llorente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Llorente. Luis Llorente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Llorente, Luis, et al.. (2024). Inflammatory profile in patients with rheumatoid arthritis and sarcopenia. Clinical Rheumatology. 43(6). 1865–1870. 6 indexed citations
2.
3.
Torres‐Ruiz, Jiram, Alfredo Pérez‐Fragoso, José Luis Maravillas‐Montero, et al.. (2021). Neutrophil Extracellular Traps Contribute to COVID-19 Hyperinflammation and Humoral Autoimmunity. Cells. 10(10). 2545–2545. 48 indexed citations
4.
Bourlon, María T., et al.. (2020). Immunosenescence profile and expression of the aging biomarker (p16INK4a) in testicular cancer survivors treated with chemotherapy. BMC Cancer. 20(1). 882–882. 18 indexed citations
5.
Llorente, Luis, et al.. (2020). Phimosis: A rare complication of immunotherapy with durvalumab. Urology Case Reports. 33. 101350–101350.
6.
Pérez-Patrigeón, Santiago, et al.. (2019). Inhibition of HIV-1 envelope-dependent membrane fusion by serum antilymphocyte autoantibodies is associated with low plasma viral load. Immunology Letters. 211. 33–40. 1 indexed citations
7.
Contreras, Alan G., Josefina Alberú, Luis Llorente, et al.. (2018). Value of C3d assay and IgG subclass in the prediction of the flow cytometry cross-match result for renal transplantation. Transplant Immunology. 50. 8–14. 2 indexed citations
8.
Atisha‐Fregoso, Yemil, Guadalupe Lima, Rosalinda Posadas‐Sánchez, et al.. (2018). C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population. Clinical Rheumatology. 37(7). 1817–1824. 9 indexed citations
9.
Fonseca‐Camarillo, Gabriela, Janette Furuzawa‐Carballeda, Luis Llorente, & Jesús K. Yamamoto‐Furusho. (2012). IL-10— and IL-20—Expressing Epithelial and Inflammatory Cells are Increased in Patients with Ulcerative Colitis. Journal of Clinical Immunology. 33(3). 640–648. 47 indexed citations
10.
Rodrı́guez-Reyna, Tatiana Sofia, et al.. (2011). Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study. Rheumatology International. 32(9). 2653–2660. 57 indexed citations
11.
Furuzawa‐Carballeda, Janette, Guadalupe Lima, Juan Jakez-Ocampo, & Luis Llorente. (2011). Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study. European Journal of Clinical Investigation. 41(10). 1037–1046. 25 indexed citations
12.
Garcı́a-Muñoz, Ricardo, Carlos Panizo, Maurizio Bendandi, & Luis Llorente. (2009). Autoimmunity and lymphoma: Is mantle cell lymphoma a mistake of the receptor editing mechanism?. Leukemia Research. 33(11). 1437–1439. 15 indexed citations
13.
Ruı́z-Argüelles, Alejandro & Luis Llorente. (2006). The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmunity Reviews. 6(3). 155–161. 85 indexed citations
14.
Soto‐Vega, Elena, Yvonne Richaud‐Patín, & Luis Llorente. (2005). Human leukocyte antigen class I, class II, and tumor necrosis factor-alpha polymorphisms in a healthy elder Mexican Mestizo population. Immunity & Ageing. 2(1). 13–13. 13 indexed citations
15.
Portales‐Pérez, Diana Patricia, D Alarcón-Segovia, Luis Llorente, et al.. (1998). Penetrating Anti-DNA Monoclonal Antibodies Induce Activation of Human Peripheral Blood Mononuclear Cells. Journal of Autoimmunity. 11(5). 563–571. 33 indexed citations
16.
Émilie, Dominique, Weiping Zou, R Fior, et al.. (1997). Production and Roles of IL-6, IL-10, and IL-13 in B-Lymphocyte Malignancies and in B-Lymphocyte Hyperactivity of HIV Infection and Autoimmunity. Methods. 11(1). 133–142. 26 indexed citations
17.
Llorente, Luis, Weiguo Zou, Yves Lévy, et al.. (1995). Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.. The Journal of Experimental Medicine. 181(3). 839–844. 440 indexed citations
18.
Vidaller, Antonio, et al.. (1992). Hyperprolactinemia inhibits natural killer (NK) cell functionin vivo and its bromocriptine treatment not only corrects it but makes it more efficient. Journal of Clinical Immunology. 12(3). 210–215. 33 indexed citations
19.
Llorente, Luis, Marie‐Claude Crevon, Saoussen Karray, et al.. (1989). Interleukin (IL) 4 counteracts the helper effect of IL 2 on antigen‐activated human B cells. European Journal of Immunology. 19(4). 765–769. 24 indexed citations
20.
Díaz-Jouanen, E, et al.. (1977). Cold-reactive lymphocytotoxic antibodies in mixed connective tissue disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(1). 4–10. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth M. Kaufman Breakdown of academic impact, for papers by Jorge Alcocer‐Varela Breakdown of academic impact, for papers by Shunsei Hirohata Breakdown of academic impact, for papers by Paola Migliorini Breakdown of academic impact, for papers by Thierry Martin Breakdown of academic impact, for papers by Michael J. Townsend Breakdown of academic impact, for papers by Eric S. Sobel Breakdown of academic impact, for papers by Shingo Nakayamada Breakdown of academic impact, for papers by Frédérique Ponchel Breakdown of academic impact, for papers by Naoyuki Tsuchiya
Rankless by CCL
2026